Affimed N.V. (AFMDQ) vs Eiger BioPharmaceuticals, Inc. (EIGRQ)
Affimed N.V. and Eiger BioPharmaceuticals, Inc. are both Biotechnology companies. Affimed N.V. and Eiger BioPharmaceuticals, Inc. are of similar size ($2.8M and $2.6M). Eiger BioPharmaceuticals, Inc. grew revenue faster over the last twelve months: 17.0% against −95.2%. Eiger BioPharmaceuticals, Inc. has the higher net margin (−475.3% vs −7,834.6%) and the higher return on invested capital (−3,674.6% vs −13,558.8%). Across the 15 metrics below, Eiger BioPharmaceuticals, Inc. leads on 8 and Affimed N.V. on 7.
Valuation
Profitability
| Metric | AFMDQ | EIGRQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 99.85% | 65.16% |
| Operating margin | (7,858.63%) | (455.12%) | 0.00% |
| Net margin | (7,834.59%) | (475.26%) | 0.00% |
| Free cash flow margin | (8,603.91%) | (474.11%) | 0.00% |
| Return on equity | (148.64%) | (367.00%) | (57.72%) |
| Return on assets | (86.68%) | (94.31%) | (49.22%) |
| Return on invested capital | (13,558.83%) | (3,674.55%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack